Wednesday February 4, 9:51 am Eastern Time
Company Press Release
Scottsdale Scientific Announces That Their Product, HomoCysteine
Metabolism Formula, Helps Reduce Cardiovascular Risk and Birth
Defects
SCOTTSDALE, Ariz.--(BW HealthWire)--Scottsdale Scientific, Inc. (symbol:STDS), through its wholly owned subsidiary,
NutriCology, Inc. has introduced a specific homocysteine metabolizing formula which contains eight (8) different ingredients
developed to reduce homocysteine levels. HomoCysteine Metabolism Formula was developed to reduce the formation of the
amino acid homocysteine, which is toxic when it accumulates beyond low/levels. It has been shown that nutritional deficiencies
in Vitamin B12, folic acid and possibly B6 can lead to increased homocysteine, which can cause vascular damage and elevate
cardiovascular risk. Deficiencies in folic acid during pregnancy will increase the risk of neutral tube defects (birth defects) in the
infant.
A recent article in the Journal of the American Medical Association (1) carefully reviewed over two dozen studies related to
homocysteine and coronary artery disease plus nearly a dozen studies of folic acid effects on total homocysteine levels.
Overwhelming evidence points to a positive correlation between elevated homocysteine levels and risk of cardiovascular
disease.
HomoCysteine Metabolism Formula is one of over 250 products within the NutriCology/Allergy Research Group product line
that offers advanced life enhancement nutraceuticals. (Nutraceuticals are nutritional products with potential therapeutic value.)
Scottsdale Scientific, Inc., through its wholly owned subsidiary, NutriCology, Inc. is an innovative leader in nutraceutical
research and product formulation. Since 1979, the Company has been noted for quality, hypoallergenic nutritional supplements
and in 1997 supplied products to approximately 5,000 physicians and health care practitioners. NutriCology was the first in the
US to introduce numerous specialty products including melatonin, a neurohormone, germanium sesquioxide (a trace mineral),
AntiOx (TM), a broad spectrum antioxidant and Buffered Vitamin C. Buffered Vitamin C was tested at the Haight Ashbury
Clinic, in San Francisco as a nutritional supplement for its value (associated with medical treatment) for opiate and stimulate
abusers.
Reference: 1. Boushey CJ; Beresford SAA; Omenn GS; Motulska AG (1995) ''A Quantitative assessment of plasma
homocysteine as a risk factor for vascular disease; probable benefits of increasing folic acid intakes.'' Journal of the American
Medical Association, 274: 1049.
Disclaimer: This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of
1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or
performance and underlying assumptions and other statements, which are other than statements of historical facts. These
statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance,
changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks
defined in this document and in statements filed from time to time with the Securities and Exchange Commission. All such
forward-looking statements, whether written or oral, and whether made by or on behalf of the Company are expressly qualified
by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In
addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances
after the date hereof.
Contact:
Scottsdale Scientific, Inc.
George Mahfouz, Jr., 888/607-5399 |
